4//SEC Filing
Hamel Lawrence G 4
Accession 0001209191-20-007738
CIK 0001427925other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 9:08 PM ET
Size
8.2 KB
Accession
0001209191-20-007738
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-06+100,000→ 100,000 totalExercise: $1.72Exp: 2030-02-06→ Common Stock (100,000 underlying) - Award
Common Stock
2020-02-06+50,000→ 133,382 total
Holdings
- 29,795(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units shall vest in three equal consecutive annual installments on February 6, 2021, February 6, 2022 and February 6, 2023.
- [F3]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the grant date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 9:08 PM ET
- Size
- 8.2 KB